Capsida Biotherapeutics Presents New Data Validating Potential of Its Targeted, Non-invasive Gene Therapy Platform at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
/PRNewswire/ -- Capsida Biotherapeutics ("Capsida"), the only fully integrated gene therapy platform company that through intravenous (IV) delivery of a...
United States Brandon Wheeler Peter Anastasiou Nick Goeden Prnewswire Capsida Biotherapeutics Nicholas Flytzanis
Source: prnewswire.com